BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1176776)

  • 1. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND; Kreider JW; Horetsky RL
    Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells.
    Dunlop MB; Blanden RV
    Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the in vitro secondary response to syngeneic tumor and of in vivo tumor therapy with immune cells by culture-induced suppressor cells.
    Greenberg PD; Cheever M; Fefer A
    J Immunol; 1979 Aug; 123(2):515-22. PubMed ID: 222839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
    Lando PA; Edgington TS
    J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells.
    Bernstein ID; Cohen EF; Wright PW
    J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacy.
    Cheever MA; Greenberg PD; Fefer A
    J Natl Cancer Inst; 1981 Jul; 67(1):169-73. PubMed ID: 6942187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.
    Paul RD; Lopez DM
    Cancer Res; 1987 Feb; 47(4):1105-10. PubMed ID: 2879623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.